Rheumatoid arthritis is more common in women and often starts in middle age. Now, doctors are hopeful about a new drug. It does more than just control the pain. It also attacks the disease itself to help restore function.
But that's not what makes this drug such a big deal. Tofacitinib, made by Pfizer, is the first in its class available in pill form, rather than injection. That's huge because doctors say it's important for arthritis patients to have multiple drug options. And so far, the only side effects with tofacitinib are a headache and respiratory infection in some people. The okay from the FDA is expected any day now.
Copyright 2012 KCBD. All rights reserved.